Pulse Pharmaceuticals Private Limited

Pulse Pharmaceuticals Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24239TG1997PTC026151 Incorporated 09 January 1997 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma MSME · Medium
Data last updated
Revenue · FY 2024
₹145.08 Cr
▼ 1% YoY
Net loss · FY 2024
₹14.74 Cr
Net margin -10.2%
EBITDA · FY 2024
₹2.25 Cr
EBITDA margin 1.6%
Authorised capital
₹8.54 Cr
Registered with MCA
Paid-up capital
₹7.94 Cr
Issued & subscribed
Open charges
₹80.28 Cr
Satisfied ₹44.05 Cr
Company age
29 yrs
Est. 1997
Employees · EPFO
954
Provident fund records

About Pulse Pharmaceuticals Private Limited

Data last updated:

Pulse Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 January 1997 and has been in existence for over 29 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG1997PTC026151. Its GSTIN is 36AACCP7815R1ZQ (Telangana). The company holds 17 GST registrations, of which 14 are active.

The company has an authorised share capital of ₹8.54 Cr and a paid-up capital of ₹7.94 Cr. It is led by directors including Rambhau Devraj and Suresh Babu Katragadda.

Its last annual general meeting (AGM) was held on 28 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No.18/1 Sector – III HUDA Techno Enclave Hitech City Madhapur, Hyderabad, Telangana, India – 500081.

As per the financials filed for FY 2024, the company reported a revenue of ₹145.08 Cr, a decline of 1% compared to the previous year. For the same year it recorded a net loss of ₹14.74 Cr (net margin -10.2%) and EBITDA of ₹2.25 Cr (EBITDA margin 1.6%). Revenue has declined at a compounded annual rate (CAGR) of 8% over three years and 30% over five years.

The company has about 954 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Pulse Pharma. As per MCA filings, the company has open charges of ₹80.28 Cr and satisfied charges of ₹44.05 Cr on record. Court records list 16 cases involving the company, including 13 filed by the company and 3 filed against it; 6 cases are pending. The company has 7 deals on record (5 secondary share transfers, 2 rights issues); the latest was in March 2020. Its 6 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 2 smaller; the largest is Sionc Pharmaceuticals Private Limited with revenue of ₹147.51 Cr. The company has 12 MSME Form 1 returns on record between 2019 and 2023, listing 2,259 overdue payments to 280 micro and small suppliers.

Pulse Pharmaceuticals Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-09-0009156). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pulsepharma.net.

Company details

CIN U24239TG1997PTC026151
Registration Number 026151
Incorporation Date 09 January 1997
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 28 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TS-09-0009156
Key People
Rambhau Devraj Director Suresh Babu Katragadda Director Divya Katragadda Director

Recognitions & Rankings of Pulse Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Medium (2023-24)
Udyam number
UDYAM-TS-09-0009156

Contact details

Pulse Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its website is pulsepharma.net. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    pulsepharma.net
  • Social Media
  • Registered Address
    Plot No.18/1 Sector – III HUDA Techno Enclave Hitech City Madhapur, Hyderabad, Telangana, India – 500081
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Pulse Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Pulse Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Pulse Pharmaceuticals operates one associated brand: Pulse Pharma. Each brand links to its own profile.

BrandDescriptionWebsite
Pulse Pharma
Diversified generic medicines and nutritional supplements are manufactured and supplied.pulsepharma.net

Business activity

The main business activity of Pulse Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Pulse Pharmaceuticals Private Limited, buy the company report.

Financials of Pulse Pharmaceuticals Private Limited

FY 2024 filings available

Pulse Pharmaceuticals Private Limited reported revenue of ₹145.08 Cr (down 1% YoY) for FY 2024.

Revenue · FY 2024
₹145.08 Cr ▼ 1%
Net loss · FY 2024
₹14.74 Cr margin -10.2%
EBITDA · FY 2024
₹2.25 Cr margin 1.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 1%
3 years · compounded
▲ 8%
5 years · compounded
▼ 30%
EBITDA CAGR growth
1 year
▼ 85%
3 years · compounded
▼ 42%
5 years · compounded
▲ 25%

Revenue has declined at a compounded annual rate (CAGR) of 30% over five years, including a 1% fall in the latest year. EBITDA fell 85% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹145.08 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.25 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹14.74 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin1.6%
Net Profit Margin-10.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Pulse Pharmaceuticals Private Limited, buy the company report.

Board of directors of Pulse Pharmaceuticals Private Limited

Pulse Pharmaceuticals has 6 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Rambhau DevrajDirector01 Jun 201511 Years 4 MonthsCurrent
Suresh Babu Katragadda
Also directs: Pulse Nutri Science Private Limited
Director01 Jun 201511 Years 4 MonthsCurrent
Divya Katragadda
Also directs: Vizag International Private Limited
Director09 May 20197 Years 5 MonthsCurrent
Srikanth Choudary Myneni
Also directs: Srishti Udyog LLP, Vizag International Private Limited
Director01 Sep 20179 Years 1 MonthsCurrent
Venkat Ram Babu Katragadda
Also directs: Pulse Nutri Science Private Limited
Director09 Jan 199729 Years 9 MonthsCurrent
Venkateswarlu Nelabhotla
Also directs: Ezitaa Health & Wellness Private Limited, Vyome Biosciences Private Limited, Vyome Therapeutics Limited and 1 more
Director10 Nov 20223 Years 11 MonthsCurrent
View all directors

Peer comparison

Pulse Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Sionc Pharmaceuticals Private Limited₹147.51 Cr (FY 2024)13.0%Visakhapatnam, Andhra Pradesh, India
Canton Laboratories Private Limited₹147.08 Cr (FY 2025)26.0%Vadodara, Gujarat, India
Murli Krishna Pharma Private Limited₹146.68 Cr (FY 2025)-21.0%Pune, Maharashtra, India
Raman & Weil Private Limited₹145.87 Cr (FY 2025)7.0%Mumbai, Maharashtra, India
Pulse Pharmaceuticals Private Limitedthis company₹145.08 Cr (FY 2024)-₹14.74 Cr-10.2%-1.0%954Hyderabad, Telangana, India
Goodway Chemicals Private Limited₹144.1 Cr (FY 2025)-12.0%Mumbai, Maharashtra, India
Immacule Lifesciences Private Limited₹143.18 Cr (FY 2025)34.0%Nalagarh, Himachal Pradesh, India

To see the full peer comparison of Pulse Pharmaceuticals Private Limited, buy the company report.

Auditor

Pulse Pharmaceuticals Private Limited is audited by A B V K AND ASSOCIATES for the financial year 2024.

Auditor firmFinancial yearFirm registration number
A B V K AND ASSOCIATESFY 2024016392S

Shareholding

The shareholding of Pulse Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Pulse Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹80.28 Cr
Satisfied charges
₹44.05 Cr
Breakdown by lending institutions
Others₹80.19 Cr
Hdfc Bank Limited₹0.10 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
31 Jul 2023100766649Others₹1.49 CrOpen
28 May 2023100731236Others₹1.4 CrOpen
28 Mar 2023100691714Others₹7 CrOpen
03 Nov 2021100515620Hdfc Bank Limited₹9.71 LakhOpen
17 Aug 200910177916Others₹70.29 CrOpen

To see the full charge records of Pulse Pharmaceuticals Private Limited, buy the company report.

Total charge records: 14 View all charges

Deals & funding

Pulse Pharmaceuticals Private Limited has 7 deals on record (5 secondary share transfers, 2 rights issues); the latest was in March 2020.

Total deals
7
Secondary share transfers
5
Rights issues
2

Deals on record (5 of 7)

WhenDealAmountParties
Mar 2020Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Mar 2019Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Mar 2018Secondary share transferUndisclosedBuyer: 2 individuals
Seller: an individual
Jul 2017Rights issue₹1.5 CrInvestors: an individual
Mar 2017Secondary share transferUndisclosedBuyer: an individual
Seller: an individual

To see the full deal history of Pulse Pharmaceuticals Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Pulse Pharmaceuticals Private Limited was last rated by Crisil on 07 Jul 2020.

Rating agencyRated onRating
Crisil07 Jul 2020

To see the full credit ratings and regulatory alerts of Pulse Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

Pulse Pharmaceuticals Private Limited has 12 MSME Form 1 returns on record between 2019 and 2023, listing 2,259 overdue payments to 280 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 280)

SupplierAmount dueDue sinceReported on
an individual supplier
an individual supplier
an individual supplier
Precise Biopharma Private Limited
an individual supplier

To see the full MSME payment records of Pulse Pharmaceuticals Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Pulse Pharmaceuticals Private Limited has a workforce of 954 employees on its EPFO records as of Mar 11, 2025, across 1 active EPFO establishment.

Employee count
954
Active EPFO establishments
1
Employee growth
-2.55%

GST

Pulse Pharmaceuticals has 17 GST registrations: 14 active and 3 cancelled or inactive. The first 4 active GSTINs are listed below.

Total GSTINs
17
Active
14
Cancelled / inactive
3
GSTINStateStatusRegistered on
36AACCP7815R1ZQTelanganaActive01 Jul 2017
05AACCP7815R1ZVUttarakhandActive01 Jul 2017
08AACCP7815R1ZPRajasthanActive01 Jul 2017
09AACCP7815R1ZNUttar PradeshActive01 Jul 2017

To see the full GST registrations and return filing status of Pulse Pharmaceuticals Private Limited, buy the company report.

Recent activity

Pulse Pharmaceuticals Private Limited has 15 board changes on record since 1997: 6 appointments and 9 cessations. The latest: Venkateswarlu Nelabhotla ceased to be Additional Director on 28 Sep 2023.

Charges
A charge registered on 03 Nov 2020 via Charge ID 100389612 with Hdfc Bank Limited was fully satisfied on 08 Nov 2025.
Charges
A charge registered on 31 Jan 2021 via Charge ID 100418030 with Others was fully satisfied on 08 Oct 2025.
Charges
A charge registered on 27 Feb 2020 via Charge ID 100333122 with Others was fully satisfied on 08 Oct 2025.
Charges
A charge registered on 14 Jan 2020 via Charge ID 100334911 with Axis Bank Limited was fully satisfied on 08 Oct 2025.
Charges
A charge registered on 08 Nov 2019 via Charge ID 100303461 with Others was fully satisfied on 08 Oct 2025.
Charges
A charge registered on 30 Nov 2023 via Charge ID 100836811 with Others was fully satisfied on 29 May 2025.
Charges
A charge registered on 18 Feb 2022 via Charge ID 100559270 with Others was fully satisfied on 20 May 2025.
AGM
Pulse Pharmaceuticals Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records.
Filing
Pulse Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge with Others amounted to Rs. 5.00 Cr with Charge ID 100836811 was registered on 30 Nov 2023.
Ceased
Venkateswarlu Nelabhotla ceased to be Additional Director.
Charges
A charge with Others amounted to Rs. 1.49 Cr with Charge ID 100766649 was registered on 31 Jul 2023.

32 earlier events are in the company report.

News

Frequently asked questions

Pulse Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 January 1997 (29+ years old) and is registered under CIN U24239TG1997PTC026151.

Pulse Pharmaceuticals has 6 current directors:

The latest financial statements of Pulse Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 28 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Pulse Pharmaceuticals is 36AACCP7815R1ZQ, registered in Telangana. The company has 17 GST registrations in all, of which 14 are active and 3 are cancelled or inactive. Other active GSTINs include 05AACCP7815R1ZV (Uttarakhand), 08AACCP7815R1ZP (Rajasthan), 09AACCP7815R1ZN (Uttar Pradesh).

The CIN (Corporate Identification Number) of Pulse Pharmaceuticals is U24239TG1997PTC026151. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Pulse Pharmaceuticals has 16 court cases on record: 13 filed by the company and 3 filed against it. 6 are pending. Most are in the high courts.

Pulse Pharmaceuticals was incorporated on 09 January 1997, making it 29+ years old. It is registered with the Registrar of Companies, Hyderabad.

Pulse Pharmaceuticals has 7 deals on record (5 secondary share transfers, 2 rights issues); the latest was in March 2020.

The peers of Pulse Pharmaceuticals by revenue are Sionc Pharmaceuticals Private Limited, Canton Laboratories Private Limited, Murli Krishna Pharma Private Limited, Raman & Weil Private Limited, Goodway Chemicals Private Limited and 1 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Venkateswarlu Nelabhotla ceased to be Additional Director on 28 Sep 2023. Venkateswarlu Nelabhotla was appointed as Director on 10 Nov 2022. Divya Katragadda was appointed as Director on 09 May 2019. Pulse Pharmaceuticals has 15 board changes on record in total.

Yes, Pulse Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-TS-09-0009156).

Pulse Pharmaceuticals has 12 MSME Form 1 returns on record between 2019 and 2023, listing 2,259 overdue payments to 280 micro and small suppliers. The latest return was filed on 22 Apr 2024.